KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to $3.0 million.

  • Opko Health's Share-based Compensation rose 7.14% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 1.85%. This contributed to the annual value of $11.0 million for FY2024, which is 3.20% down from last year.
  • Per Opko Health's latest filing, its Share-based Compensation stood at $3.0 million for Q3 2025, which was up 36.36% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Share-based Compensation registered a high of $7.6 million during Q1 2022, and its lowest value of $2.2 million during Q2 2025.
  • Over the past 3 years, Opko Health's median Share-based Compensation value was $2.7 million (recorded in 2023), while the average stood at $2.7 million.
  • In the last 5 years, Opko Health's Share-based Compensation spiked by 187.76% in 2022 and then slumped by 64.33% in 2023.
  • Opko Health's Share-based Compensation (Quarterly) stood at $3.7 million in 2021, then declined by 13.75% to $3.2 million in 2022, then declined by 16.50% to $2.7 million in 2023, then increased by 14.29% to $3.0 million in 2024, then rose by 7.14% to $3.0 million in 2025.
  • Its Share-based Compensation was $3.0 million in Q3 2025, compared to $2.2 million in Q2 2025 and $2.6 million in Q1 2025.